{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:02:54Z","timestamp":1759104174873,"version":"3.44.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"OOO \u201cNPF \u201cMateria Medica Holding\u201d, Moscow, Russia"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.imlet.2019.10.015","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T12:47:05Z","timestamp":1576154825000},"page":"90-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The level of natural autoantibodies to IFN-gamma in varicella infection treated with antiviral drug Anaferon for children: A pilot study"],"prefix":"10.1016","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-0482","authenticated-orcid":false,"given":"Elena","family":"Don","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"van der Meide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery","family":"Egorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Putilovskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Tarasov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imlet.2019.10.015_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2217\/fnl.14.62","article-title":"Human-derived natural antibodies: biomarkers and potential therapeutics","volume":"10","author":"Xu","year":"2015","journal-title":"Future Neurol."},{"key":"10.1016\/j.imlet.2019.10.015_bib0010","series-title":"Natural Autoantibodies: Their Physiological Role and Regulatory Significance","first-page":"33431","author":"Shoenfeld","year":"2000"},{"key":"10.1016\/j.imlet.2019.10.015_bib0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaut.2013.01.006","article-title":"Natural autoantibodies in the physiology and pathophysiology of the immune system","volume":"41","author":"Avrameas","year":"2013","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.imlet.2019.10.015_bib0020","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/ard.61.7.598","article-title":"Autoantibodies against interleukin 1alpha in rheumatoid arthritis: association with long term radiographic outcome","volume":"61","author":"Graudal","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.imlet.2019.10.015_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2249.2009.04026.x","article-title":"Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation","volume":"158","author":"Schwartz-Albiez","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2019.10.015_bib0030","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.autrev.2008.04.011","article-title":"Role of natural antibodies in immune homeostasis: IVIg perspective","volume":"7","author":"Vani","year":"2008","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.imlet.2019.10.015_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/jir.1994.14.157","article-title":"Naturally occurring autoantibodies to interleukin-1 alpha, interleukin-6, interleukin-10, and interferon-alpha","volume":"14","author":"Bendtzen","year":"1994","journal-title":"J. Interferon Res."},{"issue":"6","key":"10.1016\/j.imlet.2019.10.015_bib0040","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-3083.1991.tb02552.x","article-title":"Anti-interleukin-6 antibodies in normal human serum","volume":"33","author":"Hansen","year":"1991","journal-title":"Scand. J. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2019.10.015_bib0045","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.autrev.2012.02.006","article-title":"Intravenous immunoglobulin: exploiting the potential of natural antibodies","volume":"11","author":"Kaveri","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"12","key":"10.1016\/j.imlet.2019.10.015_bib0050","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.4049\/jimmunol.0801562","article-title":"Exclusion of natural autoantibody-producing B cells from IgG memory B cell compartment during T cell-dependent immune responses","volume":"182","author":"Matejuk","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2019.10.015_bib0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2249.1996.d01-646.x","article-title":"Identification of human IgG autoantibodies specific for IL-10","volume":"104","author":"Menetrier-Caux","year":"1996","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2019.10.015_bib0060","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.biopha.2004.04.011","article-title":"The natural autoantibody repertoire and autoimmune disease","volume":"58","author":"Quintana","year":"2004","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.imlet.2019.10.015_bib0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/jir.1994.14.159","article-title":"Specific autoantibodies directed against interferon-\u03b1 in pharmaceutically prepared human immunoglobulin preparations","volume":"14","author":"Ross","year":"2009","journal-title":"J. Interferon Res."},{"issue":"8","key":"10.1016\/j.imlet.2019.10.015_bib0070","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/art.1780350814","article-title":"Anti-interleukin-6 autoantibodies in rheumatic diseases. Increased frequency in the sera of patients with systemic sclerosis","volume":"35","author":"Takemura","year":"1992","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.imlet.2019.10.015_bib0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-3083.1993.tb02590.x","article-title":"The detection and biological activity of human antibodies to IL-2 in normal donors","volume":"38","author":"Tiberio","year":"1993","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2019.10.015_bib0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis","volume":"132","author":"Meager","year":"2003","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2019.10.015_bib0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/jir.2010.0075","article-title":"Natural antibodies against bone morphogenic proteins and interferons in healthy donors and in patients with infections linked to type-1 cytokine responses","volume":"31","author":"Sauerborn","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.imlet.2019.10.015_bib0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02678215","article-title":"Natural antibodies to interferon-gamma","volume":"10","author":"Caruso","year":"1997","journal-title":"Biotherapy"},{"issue":"1","key":"10.1016\/j.imlet.2019.10.015_bib0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/antib5010003","article-title":"Anticytokine autoantibodies: association with infection and immune dysregulation","volume":"5","author":"Knight","year":"2016","journal-title":"Antibodies"},{"issue":"1","key":"10.1016\/j.imlet.2019.10.015_bib0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/380453","article-title":"Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity","volume":"38","author":"Doffinger","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.imlet.2019.10.015_bib0105","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2003-04-1065","article-title":"Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans","volume":"103","author":"Hoflich","year":"2004","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.imlet.2019.10.015_bib0110","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.4049\/jimmunol.175.7.4769","article-title":"Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections","volume":"175","author":"Patel","year":"2005","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2019.10.015_bib0115","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI19316","article-title":"Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma","volume":"115","author":"Kampmann","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.imlet.2019.10.015_bib0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/605581","article-title":"Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-gamma autoantibody","volume":"49","author":"Baerlecken","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.imlet.2019.10.015_bib0125","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10156-008-0662-8","article-title":"Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex","volume":"15","author":"Koya","year":"2009","journal-title":"J. Infect. Chemother."},{"issue":"13","key":"10.1016\/j.imlet.2019.10.015_bib0130","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2169\/internalmedicine.46.6452","article-title":"Disseminated Mycobacterium avium complex infection in a patient with autoantibody to interferon-gamma","volume":"46","author":"Tanaka","year":"2007","journal-title":"Intern. Med."},{"issue":"6","key":"10.1016\/j.imlet.2019.10.015_bib0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cid\/cit809","article-title":"Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-gamma autoantibody","volume":"58","author":"Czaja","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.imlet.2019.10.015_bib0140","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2012-08-452482","article-title":"Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection","volume":"121","author":"Chi","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.imlet.2019.10.015_bib0145","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1128\/JCM.03339-14","article-title":"Recurrence of disseminated Mycobacterium avium complex disease in a patient with anti-gamma interferon autoantibodies by reinfection","volume":"53","author":"Nishimura","year":"2015","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.imlet.2019.10.015_bib0150","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/infdis\/154.3.422","article-title":"Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection","volume":"154","author":"Arvin","year":"1986","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.imlet.2019.10.015_bib0155","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/infdis\/162.5.1049","article-title":"The immunogenicity of the Oka\/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content","volume":"162","author":"Bergen","year":"1990","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.imlet.2019.10.015_bib0160","first-page":"319","article-title":"Human natural antibodies to Culex quinquefasciatus: age-dependent occurrence","volume":"7","author":"Das","year":"1991","journal-title":"J. Am. Mosq. Control Assoc."},{"year":"2006","series-title":"Biology of Aging","author":"Robert","key":"10.1016\/j.imlet.2019.10.015_bib0165"},{"issue":"8","key":"10.1016\/j.imlet.2019.10.015_bib0170","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood-2013-01-474213","article-title":"Autoantibodies against cytokines: back to human genetics","volume":"121","author":"Puel","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.imlet.2019.10.015_bib0175","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10875-015-0161-5","article-title":"Late-onset disseminated Mycobacterium avium intracellulare complex infection (MAC), cerebral toxoplasmosis and Salmonella sepsis in a German Caucasian patient with unusual anti-interferon-gamma IgG1 autoantibodies","volume":"35","author":"Hanitsch","year":"2015","journal-title":"J. Clin. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2019.10.015_bib0180","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/nm.4158","article-title":"Identification of a major epitope by anti-interferon-gamma autoantibodies in patients with mycobacterial disease","volume":"22","author":"Lin","year":"2016","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.imlet.2019.10.015_bib0185","first-page":"54","article-title":"[The phenomenon of release activity and the hypothesis of \"spatial\" homeostasis]","volume":"44","author":"Epstein","year":"2013","journal-title":"Uspehi Fiziologicheskih Nauk"},{"issue":"4","key":"10.1016\/j.imlet.2019.10.015_bib0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/sym10040103","article-title":"The spatial homeostasis hypothesis","volume":"10","author":"Epstein","year":"2018","journal-title":"Symmetry"},{"issue":"5","key":"10.1016\/j.imlet.2019.10.015_bib0195","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/jmv.24717","article-title":"Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A\/California\/07\/09(H1N1) in murine model","volume":"89","author":"Don","year":"2017","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.imlet.2019.10.015_bib0200","first-page":"87","article-title":"Results of the study of the influence of anaferon for children on the life cycle of the influenza virus A\/H1N1 in vitro, Eksperimental`naya terapiya","volume":"62","author":"Emelyanova","year":"2018","journal-title":"Pathol. Physiol. Exp. Ther. Russ. J."},{"issue":"5","key":"10.1016\/j.imlet.2019.10.015_bib0205","first-page":"62","article-title":"Application of drugs based on release-active antibodies as immunotherapy agents","volume":"5","author":"Gavrilova","year":"2014","journal-title":"J. Clin. Cell. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2019.10.015_bib0210","first-page":"7","article-title":"Antiviral activity of oral ultralow doses of antibodies to gamma-interferon: experimental study of influenza infection in mice","volume":"49","author":"Sergeev","year":"2004","journal-title":"Antibiot. Khimioter."},{"issue":"6","key":"10.1016\/j.imlet.2019.10.015_bib0215","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10517-009-0378-5","article-title":"Study of efficiency of therapeutic and preventive anaferon (pediatric formulation) in mice with influenza infection","volume":"146","author":"Shishkina","year":"2008","journal-title":"Bull. Exp. Biol. Med."},{"issue":"3\u20134","key":"10.1016\/j.imlet.2019.10.015_bib0220","first-page":"32","article-title":"Use of ultralow doses of antibodies to gamma-interferon in the treatment and prophylaxis of viral infections","volume":"53","author":"Vasil\u2019ev","year":"2008","journal-title":"Antibiot. Khimioter."},{"issue":"5\u20136","key":"10.1016\/j.imlet.2019.10.015_bib0225","first-page":"17","article-title":"[Immunotropic properties of anaferon and anaferon pediatric]","volume":"58","author":"Zhavbert","year":"2013","journal-title":"Antibiot. Khimioter."},{"issue":"2","key":"10.1016\/j.imlet.2019.10.015_bib0230","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10517-009-0703-z","article-title":"Anaferon (pediatric formulation) in prophylactics of acute respiratory viral infection in children","volume":"148","author":"Kudin","year":"2009","journal-title":"Bull. Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.imlet.2019.10.015_bib0235","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/s16010096","article-title":"Use of piezoelectric immunosensors for detection of interferon-gamma interaction with specific antibodies in the presence of released-active forms of antibodies to interferon-gamma","volume":"16","author":"Don","year":"2016","journal-title":"Sensors"},{"issue":"3","key":"10.1016\/j.imlet.2019.10.015_bib0240","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/15321819.2019.1567536","article-title":"Advanced approach to activity evaluation for released-active forms of antibodies to interferon-gamma by enzyme-linked immunoassay","volume":"40","author":"Don","year":"2019","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.imlet.2019.10.015_bib0245","unstructured":"O.I. Epshtein, E.D. Goldberg, A.M. Dygay, Media and method for treating pathological syndrome. United States patent US-7572441-B2 (2009)."},{"key":"10.1016\/j.imlet.2019.10.015_bib0250","first-page":"0034","article-title":"Directive 2004\/27\/EC of the European Parliament and of the Council amending Directive 2001\/83\/EC on the Community code relating to medicinal products for human use. in: 2004\/27\/EC. (Ed.^(Eds)","author":"UNION TEPATCOTE","year":"2004","journal-title":"Off. J. L 136, Strasbourg"},{"issue":"4","key":"10.1016\/j.imlet.2019.10.015_bib0255","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jaut.2005.03.005","article-title":"Autoantibodies unmasked by redox reactions","volume":"24","author":"McIntyre","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2019.10.015_bib0260","unstructured":"https:\/\/www.labtestsonline.org.au\/learning\/test-index\/antibody-tests."},{"key":"10.1016\/j.imlet.2019.10.015_bib0265","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fimmu.2016.00198","article-title":"Role of natural autoantibodies and natural IgM anti-leucocyte autoantibodies in health and disease","volume":"7","author":"Lobo","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2019.10.015_bib0270","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2014-000009","article-title":"Therapeutic implications of autoantibodies in rheumatoid arthritis","volume":"2","author":"Aletaha","year":"2016","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.imlet.2019.10.015_bib0275","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/JTO.0b013e318215a0a4","article-title":"Clinical relevance of autoantibody detection in lung cancer","volume":"6","author":"Solassol","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.imlet.2019.10.015_bib0280","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.imlet.2019.10.015_bib0285","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1084\/jem.20101499","article-title":"Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-","volume":"208","author":"Griffin","year":"2011","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.imlet.2019.10.015_bib0290","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/CVI.00110-08","article-title":"Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins","volume":"15","author":"Simell","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2019.10.015_bib0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060726","article-title":"Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease","volume":"8","author":"Nagele","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.imlet.2019.10.015_bib0300","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/eji.1830250929","article-title":"Analysis of the natural human IgG antibody repertoire: life-long stability of reactivities towards self antigens contrasts with age-dependent diversification of reactivities against bacterial antigens","volume":"25","author":"Lacroix-Desmazes","year":"1995","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2019.10.015_bib0305","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/ije\/31.2.300","article-title":"Life course epidemiology and infectious diseases","volume":"31","author":"Hall","year":"2002","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.imlet.2019.10.015_bib0310","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4049\/jimmunol.144.2.685","article-title":"Natural antibodies to IFN-gamma in man and their increase during viral infection","volume":"144","author":"Caruso","year":"1990","journal-title":"J. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247819303736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247819303736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:38:20Z","timestamp":1759045100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247819303736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":62,"alternative-id":["S0165247819303736"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2019.10.015","relation":{},"ISSN":["0165-2478"],"issn-type":[{"type":"print","value":"0165-2478"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The level of natural autoantibodies to IFN-gamma in varicella infection treated with antiviral drug Anaferon for children: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2019.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}